TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Magnus Nylander Biocare AB
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
35
|
61
|
180 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-3
|
-229
|
63 |
| EBITDA |
-5
|
-229
|
24 |
| Total assets |
263
|
499
|
564 |
| Current assets |
246
|
482
|
545 |
| Current liabilities |
169
|
402
|
209 |
| Equity capital |
91
|
94
|
351 |
| - share capital |
67
|
67
|
73 |
| Employees (average) |
1
|
1
|
0 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
34.6%
|
18.8%
|
62.2% |
| Turnover per employee |
35
|
61 | |
| Profit as a percentage of turnover |
-8.6%
|
-375.4%
|
35.0% |
| Return on assets (ROA) |
-1.1%
|
-45.9%
|
11.2% |
| Current ratio |
145.6%
|
119.9%
|
260.8% |
| Return on equity (ROE) |
-3.3%
|
-243.6%
|
17.9% |
| Change turnover |
-27
|
-104
|
-49 |
| Change turnover % |
-43%
|
-63%
|
-21% |
| Chg. No. of employees |
0
|
1
|
-1 |
| Chg. No. of employees % | 0% | -100% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.